ANUNA
DEAD

Serial Number

97885401

Owner

Medda Inc.

Attorney

Michael B. Dodd

Filing Date

Apr 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ANUNA Trademark

Serial Number: 97885401

ANUNA is a trademark filed by Medda Inc. on April 12, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Medda Inc. (5 trademarks)

7647 Dyke Rd.
Ira, MI 48023

Entity Type: 03

Trademark Details

Filing Date

April 12, 2023

Registration Date

Not Registered

Goods & Services

Botanical supplements for general health and well-being; dietary supplements for general health and well-being; Dietary supplemental drinks; Dietary supplements; Dietary supplements for human consumption; Inhalable dietary supplements; Inhalable herbal supplements; Herbal supplements for general health and well-being; Medicinal herbal extracts for medical purposes; Herbal supplements; Homeopathic supplements; Liquid herbal supplements; Liquid nutritional supplements; Vitamin supplement patches; Vitamin supplements; Pharmaceuticals for the treatment of mental health conditions; pharmaceuticals for the treatment of depression; Pharmaceuticals for the treatment of chronic pain conditions; psychoactive medicines; psychedelic medicine; dietary and nutritional supplements containing hemp extracts derived from cannabis sativa L. with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; Nutritional supplements containing essential hemp oils found in plant extracts. Personalized herbal and dietary supplement products; Botanical drugs; Botanically derived therapeutic products; Ayurvedic products; Dietary supplements for hormonal well-being; Dietary supplements for cognitive enhancement; Dietary supplements for sleep support; Dietary supplements for energy enhancement; Dietary supplements for digestive health; Dietary supplements for anxiety relief; Dietary supplements for pain relief; Dietary supplements for libido

Mobile application for aggregating health data and information and tracking progress of health outcomes or other data; Mobile application for remote gathering and aggregating of health data and information from wireless, IoT, Bluetooth, 5G enabled digital health devices and wearable devices; computer software for the monitoring of health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use with medical clinical trials; Downloadable and non-downloadable software used to manage chronic health conditions; software used to improve health outcomes; software used to manage dietary supplement intake; software used to manage cannabinoid intake; software used to purchase natural therapeutics; clinical trial data collection, storage and analysis software; Downloadable and non-downloadable mobile, web, and software applications using artificial intelligence for use in tailoring formulation compositions, medical recommendations, holistic health recommendations, and therapeutic product purchasing; Downloadable and non-downloadable software for enabling or facilitating clinical research, therapy, telehealth, drug research and development, and monitoring real world evidence of drug and therapeutic safety and efficacy; Downloadable mobile applications using artificial intelligence for use in delivering precision medicine; Downloadable and non-downloadable mobile applications using artificial intelligence for use precision and tailored doses of bioactive substances via IoT and Bluetooth enabled smart delivery devices; Downloadable and non-downloadable mobile applications using artificial intelligence for use in communicating clinical research, data, information, and recommendations to patients, consumers, practitioners, clinical researchers, and regulatory organizations

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 9, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 9, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 15, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 15, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 16, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 16, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2023 NWOS
NEW APPLICATION ENTERED
Apr 15, 2023 NWAP